MedPath

The Effect of Perioperative Cardiac Output-guided GDT on Oxygen Delivery, Consumption, and Microcirculatory Perfusion

Not Applicable
Completed
Conditions
Caridac Output-guided Goal-directed Hemodynamic Therapy
Major Non-cardiac Surgery
Postoperative Acute Myocardial Injury
Postoperative Acute Kidney Injury
Oxygen Delivery
Oxygen Consumption
Microcirculatory Perfusion
Interventions
Other: Treatment algorithms targeting cardiac output
Registration Number
NCT05090254
Lead Sponsor
Universitätsklinikum Hamburg-Eppendorf
Brief Summary

Perioperative cardiac output-guided goal-directed therapy (GDT) triggers fluid, vasopressor, and inotrope administration assuming that optimizing cardiac output (i.e., global blood flow) ensures adequate oxygen delivery and microcirculatory perfusion - that are usually not directly monitored during goal-directed therapy. There is increasing evidence that perioperative cardiac output-guided goal-directed therapy may reduce postoperative complications compared to routine hemodynamic management in high-risk patients having major surgery. The effect of cardiac output-guided goal-directed therapy algorithms on perioperative oxygen delivery and consumption as well as microcirculatory perfusion, however, is unknown.

The investigators aim to investigate the effect of using different cardiac output-guided goal-directed therapy algorithms on perioperative oxygen delivery and consumption as well as sublingual microcirculatory perfusion compared to routine perioperative hemodynamic management in patients having major abdominal surgery with general anesthesia.

Detailed Description

Perioperative cardiac output-guided goal-directed therapy (GDT) triggers fluid, vasopressor, and inotrope administration assuming that optimizing cardiac output (i.e., global blood flow) ensures adequate oxygen delivery and microcirculatory perfusion - that are usually not directly monitored during goal-directed therapy. There is increasing evidence that perioperative cardiac output-guided goal-directed therapy may reduce postoperative complications compared to routine hemodynamic management in high-risk patients having major surgery. The effect of cardiac output-guided goal-directed therapy algorithms on perioperative oxygen delivery and consumption as well as microcirculatory perfusion, however, is unknown.

With technological advancements a distinct monitoring of oxygen delivery and consumption as well as microcirculatory perfusion in the perioperative period has become possible. Using new technologies, a detailed understanding of the effect of cardiac output-guided goal-directed therapy on perioperative oxygen delivery and consumption as well as microcirculatory perfusion is of vital importance to further develop and improve perioperative hemodynamic treatment strategies.

In this pilot randomized-controlled trial, the investigators therefore aim to investigate the effect of using different cardiac output-guided goal-directed therapy algorithms on perioperative oxygen delivery and consumption as well as sublingual microcirculatory perfusion compared to routine perioperative hemodynamic management in patients having major abdominal surgery with general anesthesia.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
78
Inclusion Criteria
  • Adult patients (≥18 years) having elective major abdominal surgery with general anesthesia
  • Expected duration of surgery at least 120 minutes
  • Planned postoperative monitoring in intensive care unit
Exclusion Criteria
  • Emergency surgery
  • Age <18 years
  • Body weight <50 kg
  • Pregnancy
  • Atrial fibrillation
  • Planned patient positioning in other position than supine position
  • Surgery within the last 30 days
  • Inaccessibility of the head during surgery
  • Peripheral artery disease stage ≥IIb
  • Chronic vasculitis
  • Supraglottic airway management
  • Enterostomy repair surgery

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Cardiac output personalization groupTreatment algorithms targeting cardiac outputPatients will be treated according to a goal-directed therapy protocol aiming at a personalized cardiac output goal determined with preoperative cardiac output assessment. Detailed protocol adapted from Nicklas, J.Y., et al., Personalised haemodynamic management targeting baseline cardiac index in high-risk patients undergoing major abdominal surgery: a randomised single-centre clinical trial. Br J Anaesth, 2020. 125(2): p. 122-132.
Cardiac output maximization groupTreatment algorithms targeting cardiac outputPatients will be treated according to a goal-directed therapy protocol aiming at a cardiac output maximization. Detailed protocol adapted from Edwards, M.R., et al., Optimisation of Perioperative Cardiovascular Management to Improve Surgical Outcome II (OPTIMISE II) trial: study protocol for a multicentre international trial of cardiac output-guided fluid therapy with low-dose inotrope infusion compared with usual care in patients undergoing major elective gastrointestinal surgery. BMJ Open, 2019. 9(1): p. e023455.
Primary Outcome Measures
NameTimeMethod
Perioperative changes in oxygen consumptionbaseline awake, after induction of general anesthesia, during the last 30 minutes of surgery, within 6 hours after surgery, day 1, 2, 3 after surgery

assessed via indirect calorimetry

Perioperative changes in oxygen deliveryafter induction of general anesthesia, during the last 30 minutes of surgery, within 6 hours after surgery, day 1, 2, 3 after surgery

assessed via blood gas analysis

Secondary Outcome Measures
NameTimeMethod
Perioperative changes of microcirculationbaseline awake, after induction of general anesthesia, during the last 30 minutes of surgery, within 6 hours after surgery, day 1, 2, 3 after surgery

assessed via Incident Darkfield technology

Perioperative changes in cardiac outputbaseline awake, after induction of general anesthesia, during the last 30 minutes of surgery, within 6 hours after surgery, day 1, 2, 3 after surgery

assessed via pulse wave analysis

Trial Locations

Locations (1)

University Medical Center Hamburg-Eppendorf

🇩🇪

Hamburg, Germany

© Copyright 2025. All Rights Reserved by MedPath